当前位置： SCI文献检索 > BMC INFECTIOUS DISEASES期刊下所有文献 > Establishment and development of national community-based collaborative innovation demonstration areas to achieve the control target of hepatitis B in China.

Establishment and development of national community-based collaborative innovation demonstration areas to achieve the control target of hepatitis B in China.

Abstract：

BACKGROUND:The major infectious diseases of hepatitis B has constituted an acute public health challenge in China. An effective and affordable HBV control model is urgently needed. A national project of Community-based Collaborative Innovation HBV (CCI-HBV) demonstration areas has optimized the existing community healthcare resources and obtained initial results in HBV control. METHODS:Based on the existing community healthcare network, CCI-HBV project combined the community health management and health contract signing service for long-staying residents in hepatitis B screening. Moreover, HBV field research strategy was popularized in CCI-HBV areas. After screening, patients with seropositive results were enrolled in corresponding cohorts and received treatment at an early stage. And the uninfected people received medical supports including health education through new media, behavior intervention and HBV vaccinations. In this process, a cloud-based National Information Platform (NIP) was established to collect and store residents' epidemiological data. In addition, a special quality control team was set up for CCI project. RESULTS:After two rounds of screening, HBsAg positive rate dropped from 5.05% (with 5,173,003 people screened) to 4.57% (with 3,819,675 people screened), while the rate of new HBV infections was 0.28 per 100 person-years in the fixed cohorts of 2,584,322 people. The quality control team completed PPS sampling simultaneously and established the serum sample database with 2,800,000 serum samples for unified testing. CONCLUSIONS:CCI-HBV project has established a large-scale field research to conduct whole-population screening and intervention. We analyzed the HBsAg prevalence and new infection rate of HBV in the fixed population for the epidemic trend and intervention effect. The purpose of CCI-HBV project is to establish and evaluate a practical model of grid management and field strategy, to realize the new goal to control hepatitis B in China. To provide policymakers with a feasible model, our results are directly applicable. TRIAL REGISTRATION:The project was funded by the Major Projects of Science Research for the 11th and 12th five-year plans of China, entitled "The prevention and control of AIDS, viral hepatitis and other major infectious diseases", Grant Nos. 2009ZX10004901, 2011ZX10004901, 2013ZX10004904, 2014ZX10004007 and 2014ZX10004008.

journal_name

BMC Infect Dis

journal_title

BMC infectious diseases

authors

Ruan B,Yu Z,Yang S,Xu K,Ren J,Yao J,Wu N,Yu C,Deng M,Xie T,Chen P,Wang C,Li Y,Zhao Y,Sheng J,Hou Y,Wu Z,Jin S,Chen Y,Li M,Zhu F,Tang H,Hao Y,Pang X,Lu L,Yang W,Yuan Z,Xu A,Li Z,Ni M,Yan Y,Zho

doi

10.1186/s12879-019-4150-9

subject

Has Abstract

pub_date

2019-07-12 00:00:00

pages

617

issue

issn

1471-2334

pii

10.1186/s12879-019-4150-9

journal_volume

pub_type

杂志文章

在线工具

Establishment and development of national community-based collaborative innovation demonstration areas to achieve the control target of hepatitis B in China.